Internet-based Behaviour Therapy for Tourette's Disorder & Chronic Tic

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).

Clinical Trial Description

The primary objective of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD). The two modalities of IBT are habit reversal training (HRT) and exposure and response prevention (ERP). Secondary objectives are to evaluate whether IBT can decrease tic frequency and tic-related impairment, and, as both HRT and ERP have been proven efficacious in treating TD/PTD face-to-face, are any of the two treatments better suited to be delivered via the internet?

The design of the study is a randomized-controlled trial with 20 participants. Participants will be stratified by ADHD/ADD status.

The treatment duration is 10 weeks.

Feasibility and acceptability will be assumed if:

- The two treatments can be successfully adapted to a therapist guided internet-delivered format (technical feasibility)

- Patients/parents are willing to try the offered treatment modalities

- Participants complete the active parts of the treatment

- Referrers are open to the idea of internet-delivered treatment for TD or PTD

- We can recruit sufficient numbers of patients for a fully powered efficacy trial

Regarding the secondary objective, the primary outcome is tic severity measured by the Yale Global Tic Severity Scale (YGTSS). Participants will be assessed directly after treatment (post), and at 3, 6 and 12 months after treatment. Assessments at post-treatment and 3 month follow up will be performed by assessors blinded to the treatment condition. After 3 months, we will naturalistically follow up patients up to 12 months after the end of treatment. Data collection will finish 12 months after treatment. ;

Study Design

Related Conditions & MeSH terms

Disease
Persistent (Chronic) Motor or Vocal Tic Disorder
Tic Disorders
Tics
Tourette Syndrome
Tourette's Disorder

Clinical Trial Details

NCT number	NCT02864589
Study type	Interventional
Source	Karolinska Institutet
Contact
Status	Completed
Phase	N/A
Start date	August 2016
Completion date	January 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02316145` - Internet-based Coaching for Young Adults With Neuropsychiatric Disorders	N/A
Completed	`NCT00706589` - Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder	Phase 3
Completed	`NCT01416441` - Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder	Phase 3
Completed	`NCT01727700` - Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder	Phase 3
Recruiting	`NCT06408662` - Remote Delivery of a Mindfulness-based Intervention for Tics	N/A
Completed	`NCT01315327` - Omega-3 Fatty Acids in Tourette's Disorder	N/A
Completed	`NCT01795105` - ABF Tourette's Disorder Post Marketing Surveillance Study
Completed	`NCT01418339` - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder	Phase 3
Completed	`NCT01585207` - Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder	Phase 1/Phase 2
Completed	`NCT01727713` - Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder	Phase 3
Completed	`NCT03042507` - Psychosocial Intervention for Young Children With Chronic Tics	N/A
Completed	`NCT03508245` - Investigating Circadian Rhythms in Youth With Persistent Tic Disorders	N/A
Completed	`NCT02413216` - TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)	N/A
Completed	`NCT01177774` - Assessment of Children With Tic Onset in the Past 6 Months
Completed	`NCT01418352` - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)	Phase 3
Recruiting	`NCT05499741` - Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder	N/A
Completed	`NCT03916055` - Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms